Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) EBT Growth (3y) (2012 - 2026)

Analysis

Illumina (ILMN) EBT Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 10.40%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -1.90%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 49.83%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 70.10%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.89%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -7.16%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 33.16%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -17.17%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 32.55%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -42.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 70.10%
Mar 29, 2026 58.91%
Dec 28, 2025 27.52%
Sep 28, 2025 27.24%
Jun 29, 2025 35.36%
Mar 30, 2025 9.14%
Sep 29, 2024 19.68%
Jun 30, 2024 -126.02%
Mar 31, 2024 -38.30%
Dec 31, 2023 -36.77%
Oct 1, 2023 -77.97%
Jul 2, 2023 -36.43%
Apr 2, 2023 -34.59%
Jan 1, 2023 -176.27%
Oct 2, 2022 -149.87%
Jul 3, 2022 -56.61%
Apr 3, 2022 -15.62%
Oct 3, 2021 21.88%
Jul 4, 2021 -3.73%
Apr 4, 2021 -8.55%